Citius Oncology, Inc. · NASDAQ:CTOR
Citius Pharmaceuticals, Inc. reported a 79.10% stake in Citius Oncology, Inc. (Schedule 13D/A)
Event Sep 10, 2025 · Filed Sep 12, 2025
Citius Pharmaceuticals, Inc. reported a 79.10% stake in Citius Oncology, Inc., 66,049,615 shares, with active intent on Sep 10, 2025. Filed Sep 12, 2025 (Schedule 13D/A).
- Stake
- 79.10%
- Shares
- 66,049,615
- Intent
- Active
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Citius Pharmaceuticals, Inc. | 79.10% | 66,049,615 |
Source
Related
- Citius Oncology, Inc.
- Citius Pharmaceuticals, Inc.
- Citius Oncology, Inc. shareholders
- Schedule 13D/A · Citius Pharmaceuticals, Inc. · Jun 4, 2026
- Schedule 13D/A · Citius Pharmaceuticals, Inc. · Dec 17, 2025
- Schedule 13D/A · Citius Pharmaceuticals, Inc. · Jul 25, 2025
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2026
- Schedule 13G/A · Armistice Capital, LLC · Feb 17, 2026
- Schedule 13G · Armistice Capital, LLC · Nov 14, 2025